marijuana stocks news

Form 8-K for TWO RIVERS WATER & FARMING CO

21-Nov-2014

Regulation FD Disclosure, Financial Statements and Exhibits

ITEM 7.01 Regulation FD DisclosurePress Release

The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act regardless of any general incorporation language in such filing.

Two Rivers Water & Farming Company announced today it has rejected Farmland Partner, Inc.’s offer to purchase and lease back irrigated farmland that Two Rivers owns on the Bessemer Ditch in Pueblo County, Colorado.

The text of the press release is attached herewith as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits(d) Exhibits.The following is a complete list of exhibits filed as part of this Report. Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.

Exhibit No. Description
99.1 Press release dated November 21, 2014* *Filed herewith


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Neptune Wellness Solutions Inc. (NEPT) Announces US$12.65 Million Registered Direct Offering

Neptune Wellness Solutions Inc. Announces US$12.65 Million Registered Direct Offering   Neptune…

Tetra Bio Pharma Inc. (TBPMF) Enters into Manufacturing Agreement with Vitiprints LLC for CAUMZ™ and HCC011

Tetra Bio-Pharma Enters into Manufacturing Agreement with Vitiprints LLC for CAUMZ™ and…

$GWPH Officially to NASDAQ Biotechnology Index

GW Pharmaceuticals Added to NASDAQ Biotechnology Index LONDON, Dec. 22, 2014 (GLOBE…

INSYS Therapeutics, Inc. (INSY) Initiates Phase 2 Clinical Trial of Cannabidiol (CBD)

INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment…